Headquartered in Vancouver, British Columbia, Canada, Immune Network Research Ltd. (INR) is a biotechnology company focused on developing therapies to restore the body's immune system.
INR is working to develop immunological products to treat diseases related to weakened immune systems through active research in immunology and the discovery of monoclonal antibodies. INR’s present focus is the study of its proprietary monoclonal antibody, mAb IF7, in primates to evaluate it for therapeutic treatment of HIV infection and AIDS.
Are You on INR's Mailing List?
NewsNOW! is an automatic e-mail alert service offered by INR. Be the first to know when news releases, media clippings or corporate updates are added to this web site.
Would You Like a Corporate Package?
Get an information package via mail by filling out the Online Info Request Form. You can also contact INR directly at Tel: (604) 222-5541 or Fax: (604) 224-0540.
